These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23864426)
1. Investigation into the feasibility of thioditaloside as a novel scaffold for galectin-3-specific inhibitors. Bum-Erdene K; Gagarinov IA; Collins PM; Winger M; Pearson AG; Wilson JC; Leffler H; Nilsson UJ; Grice ID; Blanchard H Chembiochem; 2013 Jul; 14(11):1331-42. PubMed ID: 23864426 [TBL] [Abstract][Full Text] [Related]
2. Taloside inhibitors of galectin-1 and galectin-3. Collins PM; Oberg CT; Leffler H; Nilsson UJ; Blanchard H Chem Biol Drug Des; 2012 Mar; 79(3):339-46. PubMed ID: 22136701 [TBL] [Abstract][Full Text] [Related]
3. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Stannard KA; Collins PM; Ito K; Sullivan EM; Scott SA; Gabutero E; Darren Grice I; Low P; Nilsson UJ; Leffler H; Blanchard H; Ralph SJ Cancer Lett; 2010 Dec; 299(2):95-110. PubMed ID: 20826047 [TBL] [Abstract][Full Text] [Related]
5. Lactulose as a novel template for anticancer drug development targeting galectins. Kishor C; Ross RL; Blanchard H Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors. Xu L; Hartz RA; Beno BR; Ghosh K; Shukla JK; Kumar A; Patel D; Kalidindi N; Lemos N; Gautam SS; Kumar A; Ellsworth BA; Shah D; Sale H; Cheng D; Regueiro-Ren A J Med Chem; 2021 May; 64(10):6634-6655. PubMed ID: 33988358 [TBL] [Abstract][Full Text] [Related]
7. Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors. Zhang H; Laaf D; Elling L; Pieters RJ Bioconjug Chem; 2018 Apr; 29(4):1266-1275. PubMed ID: 29474087 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of new thiodigalactoside-based chemical probes to label galectin-3. van Scherpenzeel M; Moret EE; Ballell L; Liskamp RM; Nilsson UJ; Leffler H; Pieters RJ Chembiochem; 2009 Jul; 10(10):1724-33. PubMed ID: 19492387 [TBL] [Abstract][Full Text] [Related]
9. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity. Peterson K; Kumar R; Stenström O; Verma P; Verma PR; Håkansson M; Kahl-Knutsson B; Zetterberg F; Leffler H; Akke M; Logan DT; Nilsson UJ J Med Chem; 2018 Feb; 61(3):1164-1175. PubMed ID: 29284090 [TBL] [Abstract][Full Text] [Related]
10. Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry. Fort S; Kim HS; Hindsgaul O J Org Chem; 2006 Sep; 71(19):7146-54. PubMed ID: 16958507 [TBL] [Abstract][Full Text] [Related]
11. A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model. Rajput VK; MacKinnon A; Mandal S; Collins P; Blanchard H; Leffler H; Sethi T; Schambye H; Mukhopadhyay B; Nilsson UJ J Med Chem; 2016 Sep; 59(17):8141-7. PubMed ID: 27500311 [TBL] [Abstract][Full Text] [Related]
12. C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions. Cumpstey I; Sundin A; Leffler H; Nilsson UJ Angew Chem Int Ed Engl; 2005 Aug; 44(32):5110-2. PubMed ID: 16007713 [No Abstract] [Full Text] [Related]
13. Molecular Recognition of a Thomsen-Friedenreich Antigen Mimetic Targeting Human Galectin-3. Santarsia S; Grosso AS; Trovão F; Jiménez-Barbero J; Carvalho AL; Nativi C; Marcelo F ChemMedChem; 2018 Oct; 13(19):2030-2036. PubMed ID: 30094951 [TBL] [Abstract][Full Text] [Related]
14. Elucidation of Hydrogen Bonding Patterns in Ligand-Free, Lactose- and Glycerol-Bound Galectin-3C by Neutron Crystallography to Guide Drug Design. Manzoni F; Wallerstein J; Schrader TE; Ostermann A; Coates L; Akke M; Blakeley MP; Oksanen E; Logan DT J Med Chem; 2018 May; 61(10):4412-4420. PubMed ID: 29672051 [TBL] [Abstract][Full Text] [Related]
15. Thermodynamics of bovine spleen galectin-1 binding to disaccharides: correlation with structure and its effect on oligomerization at the denaturation temperature. Schwarz FP; Ahmed H; Bianchet MA; Amzel LM; Vasta GR Biochemistry; 1998 Apr; 37(17):5867-77. PubMed ID: 9558320 [TBL] [Abstract][Full Text] [Related]
16. Structures of the Erythrina corallodendron lectin and of its complexes with mono- and disaccharides. Elgavish S; Shaanan B J Mol Biol; 1998 Apr; 277(4):917-32. PubMed ID: 9545381 [TBL] [Abstract][Full Text] [Related]
17. Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction. Sörme P; Arnoux P; Kahl-Knutsson B; Leffler H; Rini JM; Nilsson UJ J Am Chem Soc; 2005 Feb; 127(6):1737-43. PubMed ID: 15701008 [TBL] [Abstract][Full Text] [Related]
18. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1. van Hattum H; Branderhorst HM; Moret EE; Nilsson UJ; Leffler H; Pieters RJ J Med Chem; 2013 Feb; 56(3):1350-4. PubMed ID: 23281927 [TBL] [Abstract][Full Text] [Related]
19. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8. Oberg CT; Blanchard H; Leffler H; Nilsson UJ Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029 [TBL] [Abstract][Full Text] [Related]
20. Binding free energy calculations of galectin-3-ligand interactions. Mandal TK; Mukhopadhyay C Protein Eng; 2002 Dec; 15(12):979-86. PubMed ID: 12601137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]